GLP-1 drugs like Ozempic are reshaping obesity care, blending real weight loss gains with new questions about safety, access, ...

FILE - A subject's waist is measured during an obesity prevention study in Chicago on Jan. 20, 2010. For the first time in more than a decade, the number of states with rates of obesity of 35% or more ...

The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1 agonists for weight loss skyrockets, according to data from Gallup.

Obesity rates have dropped alongside surging use of Ozempic, Wegovy and other blockbuster GLP-1 weight-loss drugs, a new report shows. The obesity rate for adults in the United States slid from a ...

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

America’s obesity rates have constantly been rising. Over 40% of Americans are obese, and a whopping 73.6% of U.S. adults are overweight, according to a CDC estimate. The numbers, unfortunately, keep ...

The obesity rate in the U.S. dropped to 37% this year, representing a notable decrease after reaching a record high of 39.9% in 2022, according to data from Gallup. The decline may be in part due to ...

U.S. adult obesity prevalence has dipped slightly year over year, with fewer states reporting obesity rates at or above 35%. However, the nation continues to face a high overall obesity rate. That’s ...

For the first time in more than a decade, the number of states with rates of obesity of 35% or more has dropped, an encouraging sign that America’s epidemic of excess weight might be improving. But ...